RSV感染患儿呼吸道上皮细胞中干扰素-&lambda;1的表达水平及其与RSV载量的关系

陶美婷; 谢亚平; 刘淑萍; 陈浩峰; 黄寒; 陈敏; 钟礼立

doi:10.7499/j.issn.1008-8830.2017.06.013

PDF(1591 KB)

HTML

中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (6) : 677-681. DOI: 10.7499/j.issn.1008-8830.2017.06.013

论著·临床研究

RSV感染患儿呼吸道上皮细胞中干扰素-λ1的表达水平及其与RSV载量的关系

陶美婷, 谢亚平, 刘淑萍, 陈浩峰, 黄寒, 陈敏, 钟礼立

作者信息 +

Expression of interferon-λ1 in respiratory epithelial cells of children with RSV infection and its relationship with RSV load

TAO Mei-Ting, XIE Ya-Ping, LIU Shu-Ping, CHEN Hao-Feng, HUANG Han, CHEN Min, ZHONG Li-Li

Author information +

文章历史 +

摘要

目的了解呼吸道合胞病毒（RSV）感染患儿呼吸道上皮细胞中干扰素（IFN）-λ1的表达水平及其与RSV载量的关系。方法收集2015年6月至2016年6月期间因呼吸道感染住院患儿的鼻咽拭子标本，采用直接免疫荧光法行7种常见呼吸道病毒（含RSV）抗原检测，筛选出单纯RSV阳性患儿作为RSV感染组（n=120）；另收集同期门诊体检健康儿童鼻咽拭子标本，行7种常见呼吸道病毒检查均为阴性的儿童作为健康对照组（n=50）。对两组儿童鼻咽拭子标本行荧光定量PCR检测RSV载量和IFN-λ1 mRNA水平。结果 RSV感染组鼻咽拭子中IFN-λ1 mRNA水平显著高于健康对照组（P < 0.05），且IFN-λ1 mRNA水平与RSV载量呈正相关（r=0.56，P < 0.05）。结论 RSV可诱导呼吸道上皮细胞中IFN-λ1的表达，推测IFN-λ1在机体抗RSV感染中可能起重要作用。

Abstract

Objective To investigate the expression of IFN-λ1 in respiratory epithelial cells of children with respiratory syncytial virus (RSV) infection and its relationship with RSV load. Methods The nasopharyngeal swabs were collected from the children who were hospitalized with respiratory tract infection from June 2015 to June 2016. A direct immunofluorescence assay was used to detect the antigens of seven common respiratory viruses (including RSV) in the nasopharyngeal swabs. A total of 120 children who were only RSV positive were selected as the RSV infection group. A total of 50 children who had negative results in the detection of all viral antigens were selected as the healthy control group. Fluorescence quantitative real-time PCR was used to determine the RSV load and the expression of IFN-λ1 mRNA in the nasopharyngeal swabs of children in the two groups. Results The expression of IFN-λ1 in the RSV infection group was significantly higher than that in the healthy control group (P < 0.05). The expression of IFN-λ1 was positively correlated with RSV load (r=0.56, P < 0.05). Conclusions RSV can induce the expression of IFN-λ1 in respiratory epithelial cells, suggesting that IFN-λ1 may play an important role in anti-RSV infection.

导出引用

陶美婷, 谢亚平, 刘淑萍, 陈浩峰, 黄寒, 陈敏, 钟礼立. RSV感染患儿呼吸道上皮细胞中干扰素-λ1的表达水平及其与RSV载量的关系[J]. 中国当代儿科杂志. 2017, 19(6): 677-681 https://doi.org/10.7499/j.issn.1008-8830.2017.06.013

TAO Mei-Ting, XIE Ya-Ping, LIU Shu-Ping, CHEN Hao-Feng, HUANG Han, CHEN Min, ZHONG Li-Li. Expression of interferon-λ1 in respiratory epithelial cells of children with RSV infection and its relationship with RSV load[J]. Chinese Journal of Contemporary Pediatrics. 2017, 19(6): 677-681 https://doi.org/10.7499/j.issn.1008-8830.2017.06.013

参考文献

[1] Maggon K, Barik S. New drugs and treatment for respiratory syncytial virus[J]. Rev Med Virol, 2004, 14(3):149-168.
[2] Hasegawa K, Jartti T, Mansbach JM, et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis:multicenter cohort studies in the United States and Finland[J]. J Infect Dis, 2015, 211(10):1550-1559.
[3] Zickert A, Oke V, Parodis I, et al. Interferon (IFN)-λ is a potential mediator in lupus nephritis[J]. Lupus Sci Med, 2016, 3(1):e000170.
[4] Selvaggi C, Pierangeli A, Fabiani M, et al. Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis[J]. J Infect, 2014, 68(5):467-477.
[5] Eslam M, George J. Targeting IFN-λ:therapeutic implications[J]. Expert Opin Ther Targets, 2016, 20(12):1425-1432.
[6] Bullens DM, Decraene A, Dilissen E, et al. Type III IFN-λ mRNA expression in sputum of adult and school-aged asthmatics[J]. Clin Exp Allergy, 2008, 38(9):1459-1467.
[7] Lin M, Yu HP. Dexamethasone decreases IL-29 expression in house dust mite-stimulated human bronchial epithelial cells[J]. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(6):823-827.
[8] 王怡, 刘沙, 魏溪, 等. IL-29和TGF-β1在肺癌中的表达及临床意义[J]. 江苏大学学报(医学版), 2016, 26(5):458-460.
[9] 刘军, 刘春艳, 谢正德, 等. 儿童急性下呼吸道合胞病毒单一感染与混合感染对照研究[J]. 中国实用儿科杂志, 2015, 30(11):848-851.
[10] Iversen MB, Paludan SR. Mechanisms of type III interferon expression[J]. J Interferon Cytokine Res, 2010, 30(8):573-578.
[11] Pagliaccetti NE, Robek MD. Interferon-λ in the immune response to hepatitis B virus and hepatitis C virus[J]. J Interferon Cytokine Res, 2010, 30(8):585-590.
[12] Ilyushina NA, Donnelly RP. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate[J]. Antiviral Res, 2014, 111:112-120.
[13] Durbin RK, Kotenko SV, Durbin JE. Interferon induction and function at the mucosal surface[J]. Immunol Rev, 2013, 255(1):25-39.
[14] Dellgren C, Gad HH, Hamming OJ, et al. Human interferon-λ3 is a potent member of the type III interferon family[J]. Genes Immun, 2009, 10(2):125-131.
[15] Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-λ production in asthma exacerbations[J]. Nat Med, 2006, 12(9):1023-1026.